Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyvan Karimi Galougahi

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|December 22, 2023
The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodeling via redox and inflammatory mechanismsThomas S Hansen, Keyvan Karimi Galougahi, Owen Tang, et al.
Current Cardiology Reports|March 14, 2022
Calcific Plaque Modification by Acoustic Shockwaves: Intravascular Lithotripsy in Cardiovascular InterventionsDenizhan Ozdemir, Keyvan Karimi Galougahi, Gregory Petrossian, et al.
Circulation. Heart Failure|August 27, 2020
Targeting Cardiac Myocyte Na<sup>+</sup>-K<sup>+</sup> Pump Function With β3 Adrenergic Agonist in Rabbit Model of Severe Congestive Heart FailureNatasha A S Fry, Chia-Chi Liu, Alvaro Garcia, et al.
Physiological Reports|January 4, 2023
β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertensionKeyvan Karimi Galougahi, Yunjia Zhang, Vivian Kienzle, et al.
Expert Review of Cardiovascular Therapy|May 8, 2018
Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffoldsZiad A Ali, Keyvan Karimi Galougahi, Richard Shlofmitz, et al.
European Journal of Heart Failure|June 25, 2013
No association of G-protein-coupled receptor kinase 5 or β-adrenergic receptor polymorphisms with Takotsubo cardiomyopathy in a large Australian cohortGemma A Figtree, Richard D Bagnall, Irfan Abdulla, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 30, 2021
Acoustic Shock Waves to Modify Calcific Plaques - Intravascular Lithotripsy in the Peripheral CirculationKeyvan Karimi Galougahi, Peter A Soukas, Brian Kolski, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 30, 2020
The novel P2X7 receptor antagonist PKT100 improves cardiac function and survival in pulmonary hypertension by direct targeting of the right ventricleThomas Hansen, Keyvan Karimi Galougahi, Marie Besnier, et al.
The Journal of Biological Chemistry|February 23, 2012
Susceptibility of β1 Na+-K+ pump subunit to glutathionylation and oxidative inhibition depends on conformational state of pumpChia-Chi Liu, Alvaro Garcia, Yasser A Mahmmoud, et al.
Journal of Molecular and Cellular Cardiology|June 4, 2013
Redox-dependent regulation of the Na⁺-K⁺ pump: new twists to an old target for treatment of heart failureChia-Chi Liu, Natasha A S Fry, Elisha J Hamilton, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
American Journal of Physiology. Heart and Circulatory Physiology|December 22, 2023
The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodeling via redox and inflammatory mechanismsThomas S Hansen, Keyvan Karimi Galougahi, Owen Tang, et al.
Current Cardiology Reports|March 14, 2022
Calcific Plaque Modification by Acoustic Shockwaves: Intravascular Lithotripsy in Cardiovascular InterventionsDenizhan Ozdemir, Keyvan Karimi Galougahi, Gregory Petrossian, et al.
Circulation. Heart Failure|August 27, 2020
Targeting Cardiac Myocyte Na<sup>+</sup>-K<sup>+</sup> Pump Function With β3 Adrenergic Agonist in Rabbit Model of Severe Congestive Heart FailureNatasha A S Fry, Chia-Chi Liu, Alvaro Garcia, et al.
Physiological Reports|January 4, 2023
β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertensionKeyvan Karimi Galougahi, Yunjia Zhang, Vivian Kienzle, et al.
Expert Review of Cardiovascular Therapy|May 8, 2018
Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffoldsZiad A Ali, Keyvan Karimi Galougahi, Richard Shlofmitz, et al.
European Journal of Heart Failure|June 25, 2013
No association of G-protein-coupled receptor kinase 5 or β-adrenergic receptor polymorphisms with Takotsubo cardiomyopathy in a large Australian cohortGemma A Figtree, Richard D Bagnall, Irfan Abdulla, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 30, 2021
Acoustic Shock Waves to Modify Calcific Plaques - Intravascular Lithotripsy in the Peripheral CirculationKeyvan Karimi Galougahi, Peter A Soukas, Brian Kolski, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 30, 2020
The novel P2X7 receptor antagonist PKT100 improves cardiac function and survival in pulmonary hypertension by direct targeting of the right ventricleThomas Hansen, Keyvan Karimi Galougahi, Marie Besnier, et al.
The Journal of Biological Chemistry|February 23, 2012
Susceptibility of β1 Na+-K+ pump subunit to glutathionylation and oxidative inhibition depends on conformational state of pumpChia-Chi Liu, Alvaro Garcia, Yasser A Mahmmoud, et al.
Journal of Molecular and Cellular Cardiology|June 4, 2013
Redox-dependent regulation of the Na⁺-K⁺ pump: new twists to an old target for treatment of heart failureChia-Chi Liu, Natasha A S Fry, Elisha J Hamilton, et al.
Pageof 8